TASCENSO ODT

Peak

fingolimod lauryl sulfate

NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Dec 2021
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Jan 19, 2036
120 months away
Patent Expiry
Jan 19, 2036

Patent Records (3)

Patent #ExpiryTypeUse Code
10555902
Jan 19, 2036
U-3493
10925829
Jan 19, 2036
Product
—
9925138
Jan 19, 2036
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history